|
|
Article: Eon Labs Receives Approval For Enalapril Maleate HCTZ.
- Article from:
- Business Wire
- Article date:
- September 19, 2001
CopyrightCOPYRIGHT 2001 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Health/Medical & Business Editors
NEW YORK--(BW HealthWire)--Sept. 19, 2001
Eon Labs Manufacturing, Inc. announced that they have received their second FDA approval in two days.
In addition to an approval for Flutamide, USP Capsules, Eon Labs received approval for Enalapril Maleate HCTZ Tablets, the alternative for the $63 Million(a) antihypertensive, marketed under the brand name Vaseretic(R)(b). Eon Enalapril Maleate HCTZ Tablets will be available in the same strengths as the brand, 10/25mg and 5/12.5mg. This approval represents Eon Labs 11th of the year and puts the company on pace to exceed last years industry leading ...